EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives

Nanda Provoost, Rebecca C Fitzgerald, Judith Honing

Best Practice & Research Clinical Gastroenterology · 2025

DOI: 10.1016/j.bpg.2025.101989 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2025. Verfasst von Nanda Provoost und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, Early Detection of Cancer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Barrett's Esophagus (BE) is a precursor lesion of esophageal adenocarcinoma (EAC). To enable early detection of neoplasia, BE patients undergo regular endoscopic surveillance. However, more than 90 % of EAC patients were not previously diagnosed with the precursor BE, indicating that detection practices are inadequate. Screening for BE could be a strategy to detect BE in the general population, bridging the gap in early diagnosis. Given the limitations of affordable and accessible endoscopy methods for widespread use, efforts should prioritize targeted screening of at-risk individuals using less invasive approaches. For instance, the use of cell collection devices coupled with biomarker assays in patients with GERD could offer a more cost-effective solution to identify undiagnosed cases. In this review, we provide a comprehensive overview of the at-risk population for BE, current screening modalities, and future perspectives to pave the way for effective and practical BE screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsAdenocarcinomaEarly Detection of CancerMass ScreeningPrecancerous ConditionsHumansRisk FactorsEsophagoscopyRisk AssessmentGastroesophageal Reflux

Stichwörter der Autor:innen

Barrett's esophagusFuture perspectivesRisk stratificationScreening

Autor:innen und Institutionen

  • Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands.
  • Early Cancer Unit, University of Cambridge, Cambridge, UK.
  • Department of Gastroenterology, Erasmus MC University Medical Center Rotterdam, the Netherlands. Electronic address: j.honing@erasmusmc.nl.

Zitieren

APA

Provoost, N., Fitzgerald, R. C., & Honing, J. (2025). Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2025.101989

Vancouver

Provoost N, Fitzgerald RC, Honing J. Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives. Best Practice & Research Clinical Gastroenterology. 2025. doi:10.1016/j.bpg.2025.101989

BibTeX
@article{Provoost2025,
  author = {Provoost, Nanda and Fitzgerald, Rebecca C and Honing, Judith},
  title = {Barrett's esophagus screening: Current modalities, risk-based approaches, and future perspectives},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2025},
  doi = {10.1016/j.bpg.2025.101989}
}
Kostenlos starten →